Skip to main content

Young Caroline's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) ยท filed Sep 10, 2021

Accession no.
0001209191-21-055490
Filed
Sep 10, 2021
Trade date
May 28-Jun 30, 2021
Filing delay
105 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 23 non-derivative transactions. Open-market purchases total $1.05K. It was filed 105 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Young CarolineCIK 0001684087Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 28, 2021Common StockPPurchaseAcquired+15$2.93+$43.9512,398Direct
Jun 1, 2021Common StockPPurchaseAcquired+15$2.94+$44.112,413Direct
Jun 2, 2021Common StockPPurchaseAcquired+15$2.89+$43.3512,428Direct
Jun 3, 2021Common StockPPurchaseAcquired+15$2.81+$42.1512,443Direct
Jun 4, 2021Common StockPPurchaseAcquired+15$2.93+$43.9512,458Direct
Jun 7, 2021Common StockPPurchaseAcquired+15$2.94+$44.112,473Direct
Jun 8, 2021Common StockPPurchaseAcquired+15$2.99+$44.8512,488Direct
Jun 9, 2021Common StockPPurchaseAcquired+15$3.14+$47.112,503Direct
Jun 10, 2021Common StockPPurchaseAcquired+15$3.25+$48.7512,518Direct
Jun 11, 2021Common StockPPurchaseAcquired+15$3.18+$47.712,533Direct
Jun 14, 2021Common StockPPurchaseAcquired+15$3.09+$46.3512,548Direct
Jun 15, 2021Common StockPPurchaseAcquired+15$3.09+$46.3512,563Direct
Jun 16, 2021Common StockPPurchaseAcquired+15$3.09+$46.3512,578Direct
Jun 17, 2021Common StockPPurchaseAcquired+15$3.08+$46.212,593Direct
Jun 18, 2021Common StockPPurchaseAcquired+15$2.99+$44.8512,608Direct
Jun 21, 2021Common StockPPurchaseAcquired+15$3.14+$47.112,623Direct
Jun 22, 2021Common StockPPurchaseAcquired+15$3.05+$45.7512,638Direct
Jun 23, 2021Common StockPPurchaseAcquired+15$3.07+$46.0512,653Direct
Jun 24, 2021Common StockPPurchaseAcquired+15$3.09+$46.3512,668Direct
Jun 25, 2021Common StockPPurchaseAcquired+15$3.09+$46.3512,683Direct
Jun 28, 2021Common StockPPurchaseAcquired+15$3.16+$47.412,698Direct
Jun 29, 2021Common StockPPurchaseAcquired+15$3.03+$45.4512,713Direct
Jun 30, 2021Common StockPPurchaseAcquired+15$2.93+$43.9512,728Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)